TickerFacts.

A business in context

ADMA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001140361-26-031445

  2. 8-K · Current report

    Report date 2026-08-05 · 0001140361-26-031423 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-07-24 · 0001140361-26-029923

  4. 4 · Ownership change

    Report date 2026-07-16 · 0001140361-26-028844

  5. 8-K · Current report

    Report date 2026-06-02 · 0001140361-26-023705 · Items 5.07

  6. 4 · Ownership change

    Report date 2026-05-27 · 0001140361-26-023127

  7. 4 · Ownership change

    Report date 2026-05-12 · 0001140361-26-021150

  8. 4 · Ownership change

    Report date 2026-05-11 · 0001140361-26-020855

  9. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001140361-26-019336

  10. 8-K · Current report

    Report date 2026-05-06 · 0001140361-26-019295 · Items 2.02,9.01

  11. 8-K · Current report

    Report date 2026-05-04 · 0001140361-26-018667 · Items 8.01,9.01

  12. DEF 14A · Proxy statement

    Report date 2026-06-02 · 0001140361-26-014799

  13. 4 · Ownership change

    Report date 2026-04-01 · 0001140361-26-013206

  14. 8-K · Current report

    Report date 2026-03-27 · 0001140361-26-011569 · Items 7.01,9.01

  15. 4 · Ownership change

    Report date 2026-03-13 · 0001140361-26-009900

  16. 4 · Ownership change

    Report date 2026-03-16 · 0001140361-26-009899

  17. 8-K · Current report

    Report date 2026-03-02 · 0001140361-26-007230 · Items 7.01,8.01,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001140361-26-006815

  19. 8-K · Current report

    Report date 2026-02-20 · 0001140361-26-006781 · Items 2.02,5.02,9.01

  20. 8-K · Current report

    Report date 2026-01-12 · 0001140361-26-000906 · Items 2.02,7.01,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001140361-25-040578

  22. 8-K · Current report

    Report date 2025-11-05 · 0001140361-25-040539 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001140361-25-029177

  24. 8-K · Current report

    Report date 2025-08-05 · 0001140361-25-029143 · Items 1.01,1.02,2.02,2.03,9.01

  25. 8-K · Current report

    Report date 2025-06-04 · 0001140361-25-021440 · Items 5.07

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001140361-25-017747

  27. 8-K · Current report

    Report date 2025-05-05 · 0001140361-25-017704 · Items 2.02,8.01,9.01

  28. 8-K · Current report

    Report date 2025-04-28 · 0001140361-25-015881 · Items 8.01,9.01

  29. DEF 14A · Proxy statement

    Report date 2025-06-04 · 0001140361-25-013967

  30. 10-K · Annual report

    Report date 2024-12-31 · 0001140361-25-009257

  31. 8-K · Current report

    Report date 2025-03-03 · 0001140361-25-006745 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-02-19 · 0001140361-25-005489 · Items 5.02,9.01

  33. 8-K · Current report

    Report date 2025-01-13 · 0001140361-25-000871 · Items 7.01,9.01

  34. 8-K · Current report

    Report date 2025-01-13 · 0001140361-25-000870 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2024-12-30 · 0001140361-25-000073 · Items 5.02,9.01

  36. 8-K · Current report

    Report date 2024-12-20 · 0001140361-24-050002 · Items 8.01,9.01

  37. 8-K · Current report

    Report date 2024-11-19 · 0001140361-24-047487 · Items 5.02,9.01

  38. SC 13G/A · Ownership disclosure

    0000932471-24-000904

  39. SC 13G · Ownership disclosure

    0000914208-24-000495

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001140361-24-045693

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 3 transaction rows3PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

4 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-27
2026-05-28
Grossman Jerrold BP · Purchase
Acquired
Common Stock6400.07.91
2026-05-12
2026-05-14
Grossman Jerrold BP · Purchase
Acquired
Common Stock12500.08.01
2026-05-11
2026-05-12
Grossman Jerrold BP · Purchase
Acquired
Common Stock12500.08.01
2026-04-01
2026-04-03
Kestenberg-Messina Kaitlin M.F · Tax / exercise payment
Disposed
Common Stock20362.09.11

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001368514ADMA BIOLOGICS, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • ADMA Biologics (United States) · alias · wikidata
  • R&R ACQUISITION VI, INC · former SEC name · 2006-07-10 to 2012-02-21
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$426.45M$453.94M
2023-12-31$258.21M$282.96M
2022-12-31$154.08M$175.78M
2021-12-31$80.94M$99.73M
2020-12-31$42.22M$54.47M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗